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at	dehisced	 implant	 sites	 similarly	 reduced	defect	height	 and	 improved	 secondary	
measures,	indicating	non-inferiority.
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1  | INTRODUC TION
Since	 the	 introduction	 of	 restoratively	 driven	 implant	 placement,	
in	 which	 prosthetic	 devices	 are	 designed	 based	 on	 the	 exact	 im-
plant	 location	 (Albrektsson,	Berglundh,	&	 Lindhe,	 2003;	Garber	&	





&	 Karring,	 2003),	 with	 most	 of	 the	 resorption	 occurring	 within	
3	months	post-implantation	 (Araújo,	Wennström,	&	Lindhe,	2006).	
To	 achieve	 successful	 esthetic	 and	 functional	 results,	 it	 is	 often	
necessary	 to	preemptively	correct	 for	bone	resorption	using	bone	
augmentation,	 especially	 for	 implants	 placed	 in	 the	 esthetic	 zone	
(Khzam	et	al.,	2015;	Nisand,	Picard,	&	Rocchietta,	2015).
Many	high-quality	 studies	 investigating	guided	bone	 regenera-
tion	(GBR)	to	augment	the	lateral	alveolar	ridge	have	shown	repro-
ducible	 results	 and	high	 implant	 survival	 rates	 long	 term	 (Aghaloo	
&	 Moy,	 2007;	 Sanz-Sanchez,	 Ortiz-Vigon,	 Sanz-Martin,	 Figuero,	
&	 Sanz,	 2015).	 Studies	 have	 investigated	 the	 combination	 of	GBR	
with	 simultaneous	 and	 subsequent	 implant	 placement.	 The	 two	
approaches	achieved	similar	 survival	 rates,	 indicating	 they	are	 rel-
atively	equivalent	 (Sanz-Sanchez	et	al.,	2015).	 Importantly,	 implant	























The	 aim	 of	 this	 randomized	 controlled	 study	 was	 to	 evaluate	












2  | MATERIAL S AND METHODS
2.1 | Ethical considerations
This	multicenter	clinical	study,	involving	seven	university	clinics	and	
private	 practices	 in	 Europe,	 including	 Austria,	 Germany,	 Hungary,	
Italy,	and	Spain,	was	conducted	according	to	 the	ethical	principles	
set	 by	 the	 Declaration	 of	 Helsinki	 and	 is	 reported	 following	 the	
Consort	2010	guidelines	for	reporting	parallel	group	randomized	tri-
als	(Schulz,	Altman,	&	Moher,	2010).	(See	supplementary	material)
Ethical	 approvals	 were	 obtained	 at	 each	 center	 involved	 in	
the	study.	Approval	numbers	 for	were	as	 follows:	Protocol	54129,	





2.2 | Study design and eligibility criteria for 
participants
Study	 design	 and	 participant	 eligibility	 criteria	were	 as	 previously	




The	 primary	 inclusion	 criteria	 were	 as	 follows:	 (a)	 written	 in-
formed	consent;	(b)	≥18	years	of	age	and	ceased	growth;	(c)	physical	
and	mental	capability	to	participate	throughout	the	5-year	follow-up	
period;	 (d)	willingness	 and	 ability	 to	 comply	with	 all	 study-related	
procedures;	 (e)	need	of	a	single-unit	 implant	restoration	 in	the	an-
terior	and	premolar	areas	of	maxilla	or	mandible	with	GBR	of	bony	
defects,	defined	as	a	height	of	≥3	mm	and	≤7	mm	if	horizontal	width	
K E Y W O R D S
collagen	membrane,	dehisced	implant	sites,	guided	bone	regeneration,	randomized	clinical	
trial,	simultaneous	implant	placement











(c)	 acute,	untreated	periodontitis;	 (d)	health	condition	 that	did	not	









At	 the	 time	 of	 surgery,	 patient's	 eligibility	 was	 reassessed.	
Patients	were	included	if	they	(a)	had	sufficient	bone	volume	at	the	
implant	 site	 to	place	a	10-mm-long	 tapered	 implant,	 (b)	 had	 initial	
implant	 stability	 as	 assessed	by	hand	 testing,	 and	 (c)	 had	a	defect	
size	 that	would	classify	 for	a	GBR	procedure	 (defects	with	one	or	
two	walls	missing,	defect	height	(DH)	measured	from	the	top	of	the	





Allocation	 concealment	was	 performed	 through	 the	 electronic	


















membrane	 (either	CXP	 or	 BG)	was	 trimmed,	 positioned,	 and	 re-
hydrated	with	 sterile	 saline	 solution.	 In	 all	 cases,	 the	membrane	
was	fixed	using	either	periosteal	vertical	mattress	sutures	(Urban,	
Lozada,	Wessing,	Suarez-Lopez	Del	Amo,	&	Wang,	2016)	or	tita-
nium	cortical	bone	pins.	Both	 fixation	methods	were	used	 to	 in-
clude	 clinicians	 who	 preferred	 not	 to	 use	 pins.	 The	 numbers	 of	
patient	who	had	their	membranes	fixed	with	sutures	and	pins	were	
approximately	 equal	 between	 groups	 (pins,	 13	 CXP	 and	 12	 BG;	
sutures,	11	CXP	and	13	BG).
Provisional	prosthetic	installation	was	planned	to	be	performed	
within	 4	weeks	 after	 the	 reentry	 but	 left	 at	 the	 discretion	 of	 the	








The	 primary	 outcome	measure	 was	 defined	 as	 the	 DH	measured	
with	the	UNC	15	periodontal	probe	6	months	after	the	augmenta-
tion	procedure	and	was	reported	previously	(Wessing	et	al.,	2017).	
The	secondary	outcome	measures	evaluated	 in	 this	 report	 include	
implant	survival	and	success	rates,	peri-implant	bone	response,	soft	
tissue	 health,	 patient	 quality	 of	 life,	 and	 esthetic	 and	 functional	
satisfaction.
A	 “surviving	 implant”	was	defined	as	an	 implant	 that	 remained	





















measured	 using	 Adobe	 Illustrator	 by	 an	 independent	 radiologist	
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reference	 point,	 and	 positive	 numbers	 indicate	 bone	 levels	 above	
the	reference	point.
Bone	 level	 changes	were	 calculated	 for	 each	 side	 of	 the	 im-
plant	 (mesial	 and	 distal)	 separately.	 The	 average	 of	 mesial	 and	
distal	 changes	 is	 then	 calculated	 for	 each	 implant	 site	 (paired	 for	
each	side	between	two	different	points).	The	radiograph	collected	
at	 definitive	 prosthetic	 delivery	 was	 designated	 as	 the	 baseline.	







modified	Sulcus	Bleeding	 Index	 (mBI)	 according	 to	Mombelli	 et	 al.	
(Mombelli,	van	Oosten,	Schurch,	&	Land,	1987).
Patient	quality	of	life	was	evaluated	using	the	Oral	Health	Impact	
Profile	 (OHIP-14;	 Brennan	 &	 Spencer,	 2004).	 The	OHIP-14	 ques-
tionnaires	were	made	available	in	the	respective	local	languages	and	
validated	 translations	 and	 rated	 the	 prevalence	 of	 patients'	 func-
tional	 limitations;	physical	pain;	psychological	discomfort;	physical,	




Patient	 satisfaction	 with	 function	 and	 esthetics	 was	 assessed	
using	a	visual	analogue	scale	with	ratings	1–10,	where	10	=	fully	sat-
isfied	 and	1	=	not	 satisfied	 according	 to	Belser	 et	 al.	 (Belser	 et	 al.,	
2009).
Prior	 to	 the	 start	 of	 the	 study,	 all	 participating	 clinicians	were	
trained	 in	 the	 surgical	 protocols	 and	 collection	 of	 outcome	 mea-
sures.	This	training	included	hands-on	sessions	using	models	repre-
senting	the	study	indications.
















For	 comparison	 between	 the	 two	 randomized	 groups,	 CXP	 and	
BG,	 the	Mann–Whitney	U	 test	was	used	 for	 continuous	variables,	
Mantel–Haenszel	chi-square	test	 for	ordered	categorical	variables,	
and	Fisher's	exact	 test	 for	dichotomous	variables.	For	comparison	







3.1 | Patient enrollment and follow‐up
The	flowchart	of	the	study	is	shown	in	Figure	1.	A	total	of	49	patients	
were	included	in	the	study	and	randomized	into	two	study	groups:	
CXP	 (24	 patients,	 24	 implants)	 and	BG	 (25	 patients,	 25	 implants).	
The	baseline	patient	and	implant	site	characteristics	were	published	
previously	(Wessing	et	al.,	2017).	Two	patients	dropped	out	before	




















Clinical	photographs X X X X X X X
Implant	survival    X X X X
Implant	success       X
Radiographic	
examinations
 X    X X
PES      X X
Bleeding	index       X
OHIP−14 X X X X X X X
Patient	satisfaction      X X
Adverse	Event	reporting  X X X X X X
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the	6-month	follow-up	due	to	moving	or	not	returning	for	the	next	
procedure.	 Forty-seven	 patients	 underwent	 the	 reentry	 surgery.	
Subsequently,	 five	 additional	 patients	were	 lost	 to	 follow-up	 (two	












tissue	 conditions,	 and	 economic	 reasons.	 Two	 patients	 had	 other	
treatments	(orthodontic	treatment	and	several	implants,	one	patient	
in	 each	 treatment	 group)	 and	 still	 had	 a	 provisional	 prosthesis	 at	
the	time	of	study	completion.	Overall,	20	patients	in	the	CXP	group	




(CXP	 group),	 the	 information	 was	 not	 available.	 The	 restorations	
were	mainly	screw	retained	(34	patients).
3.3 | Outcome measures
The	 primary	 outcome	was	DH	 at	 6	months	 post-GBR,	 the	 results	
of	which	were	described	previously	 (Wessing	et	al.,	2017).	No	ad-
ditional	 DH	 analyses	 were	 performed	 in	 the	 current	 manuscript.	




reduced	by	62%	(n = 24; p	=	0.14).
F I G U R E  1  CONSORT	2010	flowchart	of	the	study
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TA B L E  2  Patient	and	implant	site	characteristics	by	patients	who	completed	follow-up	and	who	were	lost	to	follow-up
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At	1	year,	there	was	no	implant	failure	or	fracture,	and	all	surviv-
ing	 implants	were	successful,	 yielding	 the	1-year	CSR	and	success	
rate	of	100%.	No	device-related	adverse	events	were	reported	for	
either	group.
Overall,	 the	 MBLs	 remained	 stable	 from	 definitive	 prosthesis	
delivery	to	1-year	follow-up.	The	mean	MBL	was	−1.62	±	0.80	mm	
(n	=	40)	at	definitive	prosthesis	placement	and	−1.37	±	0.91	mm	(n	=	38)	






















tionnaire	 showed	 that	 overall	 patient	 discomfort	was	 6.5	 ±	 7.6	 at	
pretreatment	(CXP:	9.0	±	9.7,	n	=	20;	BG:	4.0	±	3.3,	n = 20; p	=	0.038),	
7.1	±	8.5	at	implant	insertion	(CXP:	9.0	±	10.6,	n	=	20;	BG:	5.3	±	5.4,	
n = 20; p	 =	 0.38),	 peaked	 at	 one	week	 post-surgery	with	 a	mean	
score	of	9.4	±	10.2	(CXP:	10.3	±	11.2,	n	=	20;	BG:	8.4	±	9.3,	n = 20; 
p	=	0.64),	and	from	then	on	continued	to	decrease	down	to	1.9	±	4.6	
at	the	1-year	follow-up	(CXP:	2.4	±	5.9,	n	=	20;	BG:	1.5	±	3.0,	n = 20; 
p	=	0.68),	with	no	statistical	significant	differences	between	the	two	
groups	 with	 the	 exception	 of	 the	 pretreatment	 assessment.	 The	
change	of	the	OHIP-14	scores	throughout	the	study	period	is	illus-
trated	in	Figure	3.
Mean	 functional	 and	 esthetic	 satisfaction	 scores	were	 >9.6	 at	
both	 definitive	 prosthesis	 delivery	 and	 1-year	 follow-up	 (Table	 5).	















a	 simultaneous	 approach.	 A	 systematic	 review	 and	 meta-analysis	
reported	 that	 only	75.4%	of	 the	 cases	 reached	 a	 complete	defect	
fill	(Jensen	&	Terheyden,	2009).	Findings	of	other	clinical	studies	in-
vestigating	GBR	with	 resorbable	membranes	 and	particulate	 graft	
materials	to	regenerate	dehiscence	defects	at	implant	sites	reported	
a	mean	defect	fill	of	61%–97%	(Carpio,	Loza,	Lynch,	&	Genco,	2000;	
Hammerle	 &	 Lang,	 2001;	 Nemcovsky,	 Artzi,	 Moses,	 &	 Gelernter,	
2000;	 Park	 et	 al.,	 2008;	 Tawil,	 El-Ghoule,	&	Mawla,	 2001).	 These	
data	are	in	agreement	with	the	findings	in	the	current	study,	with	a	
mean	defect	fill	of	71%.	Even	though	the	difference	between	both	
groups	was	not	statistically	significant,	 the	defect	 fill	 for	CXP	was	
noticeably	higher	with	a	mean	defect	fill	of	81%	versus	62%	for	BG.	






TA B L E  2   (Continued)
TA B L E  3  Marginal	bone	level	changes
 







Mean	±	SD	(mm) 0.22 ± 0.89 0.01 ± 0.66 0.42 ± 1.04
p-value	CXP	
versus	BG
 0.23  
Frequency N	(%) N	(%) N	(%)
>3.0	mm 1	(2.7) – 1	(5.3)
1.1	to	2.0	mm 5	(13.5) 1	(5.6) 4	(21.1)
0.1	to	1.0	mm 15	(40.5) 9	(50.0) 6	(31.6)
0 mm 1	(2.7) – 1	(5.3)
−1.0	to	−0.1	mm 14	(37.8) 7	(38.9) 7	(36.8)
−2.0	to	−1.1	mm 1	(2.7) 1	(5.6) –
494  |     URBAN et Al.












Papilla	mesial 1.00	±	0.56 1.05	±	0.51 0.91 ± 0.67 1.32	±	0.58
Papilla	distal 1.00	±	0.65 0.95	±	0.76 0.70 ± 0.47 0.84	±	0.50
Soft	tissue	level 1.35	±	0.59 1.40 ± 0.68 1.17 ± 0.78 1.37 ± 0.60
Soft	tissue	Contour 1.00 ± 0.46 1.10	±	0.45 0.83 ± 0.49 0.89 ± 0.32
Alveolar	process 1.00	±	0.65 1.15	±	0.59 0.95	±	0.42 1.00 ± 0.47
Soft	tissue	color 1.00	±	0.56 1.10	±	0.55 0.78 ± 0.60 1.11 ± 0.32
Soft	tissue	texture 1.20	±	0.52 1.35	±	0.49 1.17 ± 0.49 1.32 ± 0.48
Overall	PES 7.55	±	2.06 8.10 ± 2.34 6.48 ± 2.17 7.84 ± 1.34






























9.9 ± 0.3 9.9 ± 0.3 9.9 ± 0.3 0.27
Esthetic	satisfaction	
(mean	±	SD)




9.7 ± 0.7 9.8	±	0.5 9.6 ± 0.9 0.54
TA B L E  5  Patient-reported	functional	
and	esthetic	satisfaction








Implant	 survival	 rate	 and	 the	 implant	 success	 rate	were	excel-
lent	in	both	groups	with	a	survival	rate	of	100%	and	a	success	rate	
of	 100%	 12	 months	 post-loading,	 which	 supports	 the	 use	 of	 the	






From	 definitive	 prosthesis	 placement	 to	 1-year	 follow-up,	 the	
BG	group	showed	marginal	bone	level	changes	of	+0.42	±	1.04	mm	






































the	 treatment	 on	 the	 patient	 quality	 of	 life.	 This	 result	 correlates	


















primary	 limitation	 is	 that	 the	 study	was	 confined	 to	 investigating	




The	 present	 study	was	 powered	 to	 test	 the	 non-inferiority	 of	











trial	 resulted	 in	 safe	 bone	 augmentation	 of	 dehiscence	 defects	 at	
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